hypogonadism; t-therapy; traverse/cvd; fda

* “[The label change] does not give a clean slate to [health care professionals] who are giving testosterone treatment to people who do not have low testosterone,” Dhindsa said. “[Some clinics] are overtreating men, and then they [need] a phlebotomy to deal with the effects of excessive...